American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 3 , Pages 190-199 , May 2006

Factors contributing to nasal allergic late phase eosinophilia

Received 18 August 2005

References 

  1. Motojima S, Akutsu I, Fukuda T, et al. Clinical significance of measuring levels of sputum and serum ECP and serum IL-5 in bronchial asthma. Allergy. 1993;48:98–106
  2. Sur S, Gleich GJ, Swanson MC, et al. Eosinophilic inflammation is associated with elevation of interleukin-5 in the airways of patients with spontaneous symptomatic asthma. J Allergy Clin Immunol. 1995;96:661–668
  3. Kramer MF, Rasp G. Nasal polyposis: eosinophils and interleukin-5. Allergy. 1999;54:669–680
  4. Grevers G, Stammberger H. Sinusitis und polyposis nasi. In:  Grevers G editors. Praktische Rhinologie. München Wien Baltimore: Urban und Schwarzenberg; 1998;p. 137–152
  5. Danzig M, Cuss F. Inhibition of interleukin-5 with a monoclonal antibody attenuates allergic inflammation. Allergy. 1997;52:787–794
  6. Appenroth E, Gunkel AR, Muller H, et al. Activated and non-activated eosinophils in patients with chronic rhinosinusitis. Acta Otolaryngol Stockh. 1998;118:240–242
  7. Jankowski R. Eosinophils in the pathophysiology of nasal polyposis. Acta Otolaryngol Stockh. 1996;116:160–163
  8. Klimek L, Rasp G. Norm values for eosinophil cationic protein in nasal secretions: influence of specimen collection. Clin Exp Allergy. 1999;29:367–374
  9. Kramer MF, Pfrogner E, Ostertag P, et al. Nasal IL-16 and MIP-1 alpha in late phase allergic response. Allergy Asthma Proc. 2001;22:127–132
  10. Romagnani S. Cytokines and chemoattractants in allergic inflammation. Mol Immunol. 2002;38:881–885
  11. Sallusto F, Mackay CR, Lanzavecchia A. Selective expression of the eotaxin receptor CCR3 by human T helper 2 cells. Science. 1997;277:2005–2007
  12. Fujisawa T, Kato Y, Nagase H, et al. Chemokines induce eosinophil degranulation through CCR-3. J Allergy Clin Immunol. 2000;106:507–513
  13. Braun RK, Franchini M, Erard F, et al. Human peripheral blood eosinophils produce and release interleukin-8 on stimulation with calcium ionophore. Eur J Immunol. 1993;23:956–960
  14. Smith WB, Gamble JR, Clark-Lewis I, et al. Interleukin-8 induces neutrophil transendothelial migration. Immunology. 1991;72:65–72
  15. Sehmi R, Cromwell O, Wardlaw AJ, et al. Interleukin-8 is a chemo-attractant for eosinophils purified from subjects with a blood eosinophilia but not from normal healthy subjects. Clin Exp Allergy. 1993;23:1027–1036
  16. Bischoff SC, Brunner T, De Weck AL, et al. Interleukin 5 modifies histamine release and leukotriene generation by human basophils in response to diverse agonists. J Exp Med. 1990;172:1577–1582
  17. Kuna P, Lazarovich M, Kaplan AP. Chemokines in seasonal allergic rhinitis. J Allergy Clin Immunol. 1996;97:104–112
  18. Kuna P, Reddigari SR, Rucinski D, et al. Monocyte chemotactic and activating factor is a potent histamine-releasing factor for human basophils. J Exp Med. 1992;175:489–493
  19. Garcia-Zepeda EA, Rothenberg ME, Ownbey RT, et al. Human eotaxin is a specific chemoattractant for eosinophil cells and provides a new mechanism to explain tissue eosinophilia. Nat Med. 1996;2:449–456
  20. Walker C, Virchow JC, Brunijnzeel PL, et al. T cell subsets and their soluble products regulate eosinophilia in allergic and nonallergic asthma. J Immunol. 1991;146:1829–1835
  21. Collins PD, Marleau S, Griffiths-Johnson DA, et al. Cooperation between interleukin-5 and the chemokine eotaxin to induce eosinophil accumulation in vivo. J Exp Med. 1995;182:1169–1174
  22. Mould AW, Matthaei KI, Young IG, et al. Relationship between interleukin-5 and eotaxin in regulating blood and tissue eosinophilia in mice. J Clin Invest. 1997;99:1064–1071
  23. Ohashi Y, Nakai Y, Tanaka A, et al. Soluble vascular cell adhesion molecule-1 in perennial allergic rhinitis. Acta Otolaryngol. 1998;118:105–109
  24. Bochner BS, Klunk DA, Sterbinsky SA, et al. IL-13 selectively induces vascular cell adhesion molecule-1 expression in human endothelial cells. J Immunol. 1995;154:799–803
  25. Schleimer RP, Sterbinsky SA, Kaiser J, et al. IL-4 induces adherence of human eosinophils and basophils but not neutrophils to endothelium. Association with expression of VCAM-1. J Immunol. 1992;148:1086–1092
  26. Henderson WRJ, Lewis DB, Albert RK, et al. The importance of leukotrienes in airway inflammation in a mouse model of asthma. J Exp Med. 1996;184:1483–1494
  27. Marom Z, Shelhamer JH, Bach MK, et al. Slow-reacting substances, leukotrienes C4 and D4, increase the release of mucus from human airways in vitro. Am Rev Respir Dis. 1982;126:449–451
  28. Riechelmann H, Deutschle T, Friemel E, et al. Biological markers in nasal secretions. Eur Respir J. 2003;21:600–605
  29. Kramer MF, Ostertag P, Pfrogner E, et al. Nasal interleukin-5, immunoglobulin E, eosinophilic cationic protein, and soluble intercellular adhesion molecule-1 in chronic sinusitis, allergic rhinitis, and nasal polyposis. Laryngoscope. 2000;110:1056–1062
  30. Kramer MF, Burow G, Pfrogner E, et al. In-vitro diagnosis of chronic nasal inflammation. Clin Exp Allergy. 2004;34:1086–1092
  31. Raphael GD, Meredith SD, Baraniuk JN, et al. The pathophysiology of rhinitis II. Assessment of the sources of protein in histamine-induced nasal secretions. Am Rev Respir Dis. 1989;139:791–800
  32. Rasp G. Acoustic rhinometry: measuring the early and late phase of allergic immediate reaction in allergic rhinitis. Laryngorhinootologie. 1993;72:125–130
  33. Wang D, Clement P. Assessment of early- and late-phase nasal obstruction in atopic patients after nasal allergen challenge. Clin Otolaryngol. 1995;20:368–373
  34. Pelikan Z. Late and delayed responses of the nasal mucosa to allergen challenge. Ann Allergy. 1978;41:37–47
  35. Schumacher MJ, Pain MC. Nasal challenge testing in grass pollen hay fever. J Allergy Clin Immunol. 1979;64:202–208
  36. Richerson HB, Rajtora DW, Penick GD, et al. Cutaneous and nasal allergic responses in ragweed hay fever: lack of clinical and histopathologic correlations with late phase reactions. J Allergy Clin Immunol. 1979;64:67–77
  37. Dvoracek JE, Yunginger JW, Kern EB, et al. Induction of nasal late-phase reactions by insufflation of ragweed-pollen extract. J Allergy Clin Immunol. 1984;73:363–368
  38. Eccles R, Reilly M, Eccles KS. Changes in the amplitude of the nasal cycle associated with symptoms of acute upper respiratory tract infection. Acta Otolaryngol. 1996;116:77–81
  39. Eccles RB. The nasal cycle in respiratory defence. Acta Otorhinolaryngol Belg. 2000;54:281–286
  40. Lund VJ. Nasal physiology: neurochemical receptors, nasal cycle, and ciliary action. Allergy Asthma Proc. 1996;17:179–184
  41. Sanico AM, Koliatsos VE, Stanisz AM, et al. Neural hyperresponsiveness and nerve growth factor in allergic rhinitis. Int Arch Allergy Immunol. 1999;118:154–158
  42. Togias A. Unique mechanistic features of allergic rhinitis. J Allergy Clin Immunol. 2000;105:S599–S604
  43. Mullol J, Raphael GD, Lundgren JD, et al. Comparison of human nasal mucosal secretion in vivo and in vitro. J Allergy Clin Immunol. 1992;89:584–592
  44. Mosmann TR, Coffman RL. TH1 and TH2 cells: different patterns of lymphokine secretion lead to different functional properties. Annu Rev Immunol. 1989;7:145–173
  45. Greenfeder S, Umland SP, Cuss FM, et al. Th2 cytokines and asthma. The role of interleukin-5 in allergic eosinophilic disease. Respir Res. 2001;2:71–79
  46. Simon HU, Yousefi S, Weber M, et al. Human peripheral blood eosinophils express and release interleukin-8. Int Arch Allergy Immunol. 1995;107:124–126
  47. Humbles AA, Conroy DM, Marleau S, et al. Kinetics of eotaxin generation and its relationship to eosinophil accumulation in allergic airways disease: analysis in a guinea pig model in vivo. J Exp Med. 1997;186:601–612
  48. Dubucquoi S, Desreumaux P, Janin A, et al. Interleukin 5 synthesis by eosinophils: association with granules and immunoglobulin-dependent secretion. J Exp Med. 1994;179:703–708
  49. Howarth PH. Leukotrienes in rhinitis. Am J Respir Crit Care Med. 2000;161:S133–S136
  50. Kenney JS, Baker C, Welch MR, et al. Synthesis of interleukin-1 alpha, interleukin-6, and interleukin-8 by cultured human nasal epithelial cells. J Allergy Clin Immunol. 1994;93:1060–1070
  51. Ohkubo K, Ikeda K, Pawankar R, et al. Mechanisms of IL-6, IL-8, and GM-CSF release in nasal secretions of allergic patients after nasal challenge. Rhinology. 1998;36:156–161
  52. Rhyoo C, Sanders SP, Leopold DA, et al. Sinus mucosal IL-8 gene expression in chronic rhinosinusitis. J Allergy Clin Immunol. 1999;103:395–400
  53. Moller A, Lippert U, Lessmann D, et al. Human mast cells produce IL-8. J Immunol. 1993;151:3261–3266
  54. Teran LM, Carroll M, Frew AJ, et al. Neutrophil influx and interleukin-8 release after segmental allergen or saline challenge in asthmatics. Int Arch Allergy Immunol. 1995;107:374–375
  55. Douglass JA, Dhami D, Gurr CE, et al. Influence of interleukin-8 challenge in the nasal mucosa in atopic and nonatopic subjects. Am J Respir Crit Care Med. 1994;150:1108–1113
  56. Schweizer RC, Welmers BA, Raaijmakers JA, et al. RANTES- and interleukin-8–induced responses in normal human eosinophils: effects of priming with interleukin-5. Blood. 1994;83:3697–3704
  57. Christodoulopoulos P, Wright E, Frenkiel S, et al. Monocyte chemotactic proteins in allergen-induced inflammation in the nasal mucosa: effect of topical corticosteroids. J Allergy Clin Immunol. 1999;103:1036–1044
  58. Bischoff SC, Krieger M, Brunner T, et al. Monocyte chemotactic protein 1 is a potent activator of human basophils. J Exp Med. 1992;175:1271–1275
  59. Gu L, Tseng S, Horner RM, et al. Control of TH2 polarization by the chemokine monocyte chemoattractant protein–1. Nature. 2000;404:407–411
  60. Rollins BJ, Pober JS. Interleukin-4 induces the synthesis and secretion of MCP-1/JE by human endothelial cells. Am J Pathol. 1991;138:1315–1319
  61. Van Coillie E, Van Damme J, Opdenakker G. The MCP/eotaxin subfamily of CC chemokines. Cytokine Growth Factor Rev. 1999;10:61–86
  62. Weber M, Uguccioni M, Ochensberger B, et al. Monocyte chemotactic protein MCP-2 activates human basophil and eosinophil leukocytes similar to MCP-3. J Immunol. 1995;154:4166–4172
  63. Polentarutti N, Introna M, Sozzani S, et al. Expression of monocyte chemotactic protein-3 in human monocytes and endothelial cells. Eur Cytokine Netw. 1997;8:271–274
  64. Yamada H, Yamaguchi M, Yamamoto K, et al. Eotaxin in induced sputum of asthmatics: relationship with eosinophils and eosinophil cationic protein in sputum. Allergy. 2000;55:392–397
  65. Kitayama J, Mackay CR, Ponath PD, et al. The C-C chemokine receptor CCR3 participates in stimulation of eosinophil arrest on inflammatory endothelium in shear flow. J Clin Invest. 1998;101:2017–2024
  66. Tachimoto H, Burdick MM, Hudson SA, et al. CCR3-active chemokines promote rapid detachment of eosinophils from VCAM-1 in vitro. J Immunol. 2000;165:2748–2754
  67. Zangrilli JG, Shaver JR, Cirelli RA, et al. sVCAM-1 levels after segmental antigen challenge correlate with eosinophil influx, IL-4 and IL-5 production, and the late phase response. Am J Respir Crit Care Med. 1995;151:1346–1353
  68. Meng H, Tonnesen MG, Marchese MJ, et al. Mast cells are potent regulators of endothelial cell adhesion molecule ICAM-1 and VCAM-1 expression. J Cell Physiol. 1995;165:40–53
  69. Pawankar R, Yamagishi S, Yagi T. Revisiting the roles of mast cells in allergic rhinitis and its relation to local IgE synthesis. Am J Rhinol. 2000;14:309–317
  70. Baraniuk JN. Pathogenesis of allergic rhinitis. J Allergy Clin Immunol. 1997;99:S763–S772
  71. Drazen JM, Austen KF, Lewis RA, et al. Comparative airway and vascular activities of leukotrienes C-1 and D in vivo and in vitro. Proc Natl Acad Sci U S A. 1980;77:4354–4358
  72. Underwood DC, Osborn RR, Newsholme SJ, et al. Persistent airway eosinophilia after leukotriene (LT) D4 administration in the guinea pig: modulation by the LTD4 receptor antagonist, pranlukast, or an interleukin-5 monoclonal antibody. Am J Respir Crit Care Med. 1996;154:850–857
  73. Busse WW. Leukotrienes and inflammation. Am J Respir Crit Care Med. 1998;157:S210–S213
  74. Sedgwick JB, Calhoun WJ, Gleich GJ, et al. Immediate and late airway response of allergic rhinitis patients to segmental antigen challenge. Characterization of eosinophil and mast cell mediators. Am Rev Respir Dis. 1991;144:1274–1281
  75. Wang D, Clement P. Pathogenic mechanisms underlying the clinical symptoms of allergic rhinitis. Am J Rhinol. 2000;14:325–333
  76. Wang D, Smitz J, Waterschoot S, et al. An approach to the understanding of nasal early-phase reaction induced by nasal allergen challenge. Allergy. 1997;52:162–167

PII: S0196-0709(05)00184-5

doi: 10.1016/j.amjoto.2005.09.013

American Journal of Otolaryngology - Head and Neck Medicine and Surgery
Volume 27, Issue 3 , Pages 190-199 , May 2006

Article Tools

* Image Usage & Resolution